InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,467.83
(
-0.03%
)
US TECH 100
19,192.40
(
0.09%
)
Dow Jones
39,162.85
(
0.13%
)
Brent Oil
84.63
(
0.52%
)
Bitcoin
60,995.86
(
-1.32%
)
Post# of 252370
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

mouton29

Send PM Follow Ignore
Followers 21
Posts 2045
Boards Moderated 0
Alias Born 04/14/2007

mouton29

Member Level

Re: None

Wednesday, 04/03/2024 12:07:24 PM

Wednesday, April 03, 2024 12:07:24 PM

Post# of 252370
Re Verve: Good interview of Verve CEO, attributes safety issues in dose escalation trial of gene therapy/PCSK9 inhibition trial to lipid nanoparticle delivery system, believes second generation system will avoid the problem.

Stock fell from 14 to 8 on news, recovered a bit today.

https://www.biotechtv.com/post/verve-therapeutics-april-2-2024
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up